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Numerous metaphors have been employed to describe the achievements of the 2013 Nobel Laureates in
Physiology orMedicine, James E. Rothman, RandyW. Schekman, and ThomasC. Su¨dhof, whowere honored
for ‘‘their discoveries of machinery regulating vesicle traffic, a major transport system in our cells.’’ Most of
these metaphors referred to the mundane issue of business logistics, and there is probably no other cell type
in which the logistics problem is more pressing than in neurons.Manufacturing companies have to get
their products in the right quantity at the
right time in the right condition to the right
customer at the right location. Eukaryotic
cells have a similar logistics problem.
They produce thousands of proteins that
have to be trafficked accurately to many
different subcellular compartments. The
2013 Nobel Laureates in Physiology or
Medicine deciphered the molecular
mechanisms of the vesicle-based secre-
tory pathway that controls the fate of
proteins from their production site to their
specific target location and showed how
the secretory machinery is ‘‘honed’’ in
nerve cells for fast neurotransmitter
release at synapses.
The Neuronal Likeness of Yeast
Cells
The budding yeast Saccharomyces cere-
visiae is the genetically and physiologi-
cally best-studied eukaryotic cell, and no
neuroscientist with sufficient cell biolog-
ical knowledge would question the impor-
tance that yeast models have had for
modern neurobiology. Even clinically
focused neuroscientists have started to
use yeast cells to analyze pathomechan-
isms and develop therapies, for example,
in the context of neurodegenerative dis-
eases. However, in 1976, when Randy
W. Schekman chose Saccharomyces
cerevisiae as a model to study cell
growth and secretion, it was not clear
whether yeast cells employ a proper
secretory pathway, let alone whether any
such yeast pathway would be relevant
for human cells—or neurons.
In his Nobel Lecture at the Karolinska
Institute, Schekman emphasized that hischoice of topic and model system was
mainly influenced by George E. Palade’s
description of protein synthesis, trans-
port, and secretion in exocrine pancreatic
cells, which led to the Nobel Prize in 1974,
and by Leland H. Hartwell’s success in
using yeast genetics to decipher the
mechanisms that drive the cell-division
cycle, which was honored with the 2001
Nobel Prize. Inspired by these pioneers,
Schekman’s laboratory set out to system-
atically identify yeast mutants with aber-
rant cell-surface growth. Assuming that
such mutants would be extremely sick,
the focus was on temperature-sensitive
mutants, which turned out to be crucial
for the success of the endeavor.
The initial work of Schekman led to the
identification of mutations in 23 so-called
sec genes, which caused the accumula-
tion of vesicles and other organelles in
mutant cells (Novick and Schekman,
1979; Novick et al., 1980). The finding
that certain sec mutants accumulate ves-
icles in defined subcellular compartments
represented the first direct demonstration
of a role of transport vesicles in protein
and membrane trafficking through the
secretory pathway, a notion that had
been posed earlier by Palade. Subse-
quently, Schekman and several other
yeast geneticists identified a total of
some 100 genes with related functions.
This led ultimately—as Schekman
pointed out in his Nobel Lecture—to a
detailed definition of the ‘‘genetic contour
of the secretory pathway,’’ with indivi-
dual genes mapped to defined steps
in the pathway from protein transloca-
tion into the endoplasmic reticulum, via -
endoplasmic-reticulum-to-Golgi trans-Neuron 81,port, Golgi maintenance, and Golgi
sorting, to vesicle fusion (Figure 1). In
follow-up studies, Schekman and col-
leagues cloned the sec genes and used
biochemical and cell biological assays to
study the functions of the corresponding
SEC proteins. This work led to several
seminal discoveries, for example, of the
role of the COP-II vesicle coat in en-
doplasmic-reticulum-to-Golgi transport
(Barlowe et al., 1994).
Schekman ended his Nobel Lecture
with an excursus into human patho-
physiology, describing how mutations in
proteins involved in COP-II coat formation
lead to diseases, such as cranio-lenticulo-
sutural dysplasia in the case of mutations
of SEC23A. This justification of the
general relevance of his work may have
been necessary to impress all the modern
skeptics, who believe that molecules and
molecular mechanisms do not matter
much—particularly not in understanding
brain function. But as regards scientists
with even only a tad bit of molecular
and cellular inclination, Schekman was
preaching to the converted.
His pioneering work did not only
crucially influence the studies of his 2013
colaureates James E. Rothman and
Thomas C. Su¨dhof but has deeply pene-
trated and fostered all of cell biology,
particularly the field of molecular and
cellular neuroscience. About a third of all
proteins encoded by the human genome
require transport through the secretory
pathway, whose genetic and molecular
outline Schekman’s work has defined.
The release of growth factors, the plasma
membrane exposure of their receptors,
the transport of ion channels to the cellFebruary 19, 2014 ª2014 Elsevier Inc. 723
Figure 1. The Nobel Prize in a Nutshell
The secretory pathway and the synaptic vesicle fusion machinery. ER, endoplasmic reticulum; ERES, ER exit site. See text for details.
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neurotransmitters, the dynamic cell sur-
face exposure of neurotransmitter recep-
tors ... every aspect of brain cell biology,
and, consequently, of brain function
depends on the secretory system. It is
therefore not at all surprising that the
genes discovered by Schekman are crit-
ical for human health and have featured
very prominently in neurobiology. For
instance, mammalian SEC1 homologs
of the Munc18 family are essential re-
gulators of neurotransmitter release and
several other cellular processes, and
mammalian SEC4 homologs of the Rab
family of small GTPases regulate multiple
membrane and protein trafficking steps in
neurons, including transmitter release and
receptor recycling. The list of examples
could be continued endlessly as there
are over 100 SEC and SEC-related pro-724 Neuron 81, February 19, 2014 ª2014 Elsteins. It ends here because I, at least,
have been a ‘‘yeast believer’’ for decades.
A Biochemist’s Journey to
Neuroscience
James E. Rothman’s ‘‘maiden voyage’’
into the field of secretory trafficking
started at almost the same time as Schek-
man’s but followed a strikingly different
course. Trained as a physicist, Rothman
initially applied to do graduate work in
the neurosciences but was rejected, as
he stated in his Nobel Lecture. Thus
‘‘coerced’’ to become a biochemist
instead, Rothman continued the legacy
of Palade, one of his main inspirators, by
applying brute-force biochemistry.
At the time, Palade had put forward the
notion that transport vesicles are the
vehicles by which membranes and pro-
teins are trafficked through the secretoryevier Inc.pathway. However, it was unclear as to
how the corresponding cellular logistics
problem is solved, that is, how the right
cargo is delivered to the right place at
the right time. Rather than pursuing the
then prevalent idea that the cellular micro-
anatomy defines the specificity of cellular
trafficking, Rothman based his work on
the hypothesis that there must be an
intrinsic molecular specificity by which
transport vesicles recognize their correct
target membranes.
To test this hypothesis and search for
proteins that define the specificity of
vesicular trafficking, Rothman chose an
equally daring and ingenious cell-free
assay system that allowed him to follow
the maturation of the glycoprotein VSVG
as it is trafficked through the different
Golgi compartments (Balch et al., 1984).
Using this assay, Rothman’s group
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coat in intra-Golgi trafficking (Malhotra
et al., 1989), showed that the enzyme
NSF is required for the intra-Golgi trans-
port process and involved in regulating
vesicle fusion (Block et al., 1988), and
found that NSF requires soluble mem-
brane attachment proteins, called SNAPs
(Clary et al., 1990) (Figure 1). Subsequent
work showed that NSF and SNAPs
are the mammalian homologs of yeast
SEC18 and SEC17, respectively. This
fascinating convergence of Schekman’s
genetic and Rothman’s biochemical
studies provided a crucial cross-valida-
tion and showed that the two pioneers
were up to something of very general
relevance.
But Rothman’s initial discoveries did
not solve the cellular logistics problem.
NSF and SNAPs are soluble and addi-
tional work had indicated that they might
be involved in several different mem-
brane trafficking and fusion events. They
could not possibly be responsible for
the specificity of vesicular fusion reac-
tions, they had to have target proteins in
membranes that provide specificity and
possibly even execute fusion. In search
for these targets, Rothman turned to the
brain, where NSF and SNAPs are most
abundant. Using recombinant NSF/
SNAP complexes as an affinity matrix,
his group purified three proteins that
bound to NSF/SNAP complexes and
eluted from them upon ATP hydrolysis:
the synaptic vesicle protein VAMP/
Synaptobrevin, the presynaptic plasma
membrane protein Syntaxin, and the syn-
aptosomal protein SNAP25 (So¨llner et al.,
1993a), which Rothman collectively
termed SNAP receptors or SNAREs. At
first sight, the corresponding protein
sequencing data must have caused a
collective transient cardiac arrest in the
Rothman lab, as two of the three proteins
were already well-known suspects.
VAMP/Synaptobrevin had just been
shown to be a proteolytic substrate of
certain clostridial neurotoxins that block
neurotransmitter release, indicating a
key role in synaptic vesicle fusion
(Schiavo et al., 1992), and Syntaxin had
been discovered previously as a binding
partner of the synaptic vesicle protein
Synaptotagmin, indicating a role in syn-
aptic vesicle docking to the plasma
membrane (Bennett et al., 1992).The discovery of the SNARE proteins as
targets of the NSF/SNAP complex pro-
vided the key insight into the mechanism
of vesicle fusion, but it took quite some
time to sort out the facts. Indeed, the initial
SNARE discovery was followed by sub-
stantial controversy in the field, with mul-
tiple and often diametrically opposed
models being propagated, e.g., regarding
the role of NSF and the SNAPs in the
actual fusion reaction, or the orientation
of the SNARE proteins in the complex. In
the introduction to Rothman’s Nobel Lec-
ture by the Nobel Assembly, this phase of
model development was likened to the
maturation of a good red wine, which
needs time to develop its full body.
Ultimately, the discoveries that VAMP/
Synaptobrevin, Syntaxin, and SNAP25
form a tight complex that is dissociated
by NSF (So¨llner et al., 1993b), that
SEC18/SEC17 (i.e., NSF/SNAP) action
can precede membrane docking and
fusion (Mayer et al., 1996), that the three
SNARE proteins alone are sufficient to
execute membrane fusion in vitro (Weber
et al., 1998), and that the SNARE complex
is formed by the parallel association of
helical SNARE motifs within the three
SNARE proteins (Sutton et al., 1998)
settled the case: one SNARE motif each
of VAMP/Synaptobrevin and Syntaxin
and two SNARE motifs of SNAP25 zipper
up to form a four helix bundle and thereby
drive the membrane fusion reaction,
whereas the NSF/SNAP complex is
responsible for dissociating SNARE com-
plexes, e.g., after fusion (Figure 1). Subse-
quent studies by Rothman’s group and
several other laboratories identified
large families of VAMP/Synaptobrevin-,
Syntaxin-, and SNAP25-like proteins
with different subcellular distributions
and showed that only a subset of SNARE
protein combinations lead to SNARE
complex formation andmembrane fusion.
This work demonstrated that SNARE
proteins do not only execute the fusion
reaction but also contribute substantially
to the specificity of vesicle fusion reac-
tions, thereby helping to deal with the
notorious logistics problem in the secre-
tory pathway.
Rothman’s Nobel Lecture culminated
with a discussion of synaptic vesicle
fusion, whose speed and temporal accu-
racy continue to pose a problem for the
SNARE model of membrane fusion.Neuron 81,SNARE-mediated fusion in vitro is rather
slow and asynchronous, as is the case
with many cellular vesicle fusion reac-
tions. In contrast, neurotransmitter secre-
tion from synaptic vesicles occurs with
millisecond precision and is tightly
controlled by the intracellular Ca2+ con-
centration, which can boost the synaptic
vesicle fusion rate by up to one million
times. This discrepancy led to the notion
that SNARE-mediated synaptic vesicle
fusion must be controlled by a specialized
protein machinery that keeps some
synaptic vesicles in a fusion-ready—or
primed—state at any given time, that pre-
vents or ‘‘clamps’’ unwanted sponta-
neous fusion prior to a stimulus, and that
boosts the somewhat sluggish SNARE
machinery upon action potential induced
Ca2+ influx. Using in vitro fusion assays,
Rothman and his colleagues found that
Complexin, a protein that had previously
been shown to bind to assembled SNARE
complexes (McMahon et al., 1995) and to
be required for normal synaptic trans-
mitter release (Reim et al., 2001), can
indeed ‘‘clamp’’ SNARE-mediated fusion
(Giraudo et al., 2006). While still con-
troversial in the field of molecular and
cellular neuroscience, his ‘‘clamp’’ model
of Complexin function hasmadeRothman
a neuroscientist after all, and count-
less neuroscience colleagues, including
myself, have been deeply inspired by his
discoveries—and by his visionary and
often daring hypotheses.
A Paradigma of Molecular
Neuroscience
At the time of the SNARE complex dis-
covery, Thomas C. Su¨dhof had already
been well on his way to a systematic
molecular cartography of presynaptic
function. Su¨dhof’s choice of his research
topic was based on his fascination with
synapses, the ‘‘fundamental informa-
tion processors’’ in the brain, as he put
it in his Nobel Lecture. This fascination
with synapses had been triggered during
Su¨dhof’s graduate work with Victor
Whittaker and by the studies of Bernard
Katz, Ulf von Euler, and Julius Axelrod,
who won the Nobel Prize in 1970—and
it was fortunately not lost during a
subsequent ‘‘detour’’ into cholesterol
biology.
I vividly remember my first encounter
with Su¨dhof in 1987, a year after he hadFebruary 19, 2014 ª2014 Elsevier Inc. 725
Neuron Editorial Board member Thomas C. Su¨dhof with his wife Lu
Chen and former colleagues and coworkers after the Nobel Prize
award ceremony at the Stockholm concert hall
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the time, I was a young PhD
student with Reinhard Jahn,
who had invited Su¨dhof to
discuss what would later
become an extremely fruitful
collaboration. The two
decided no less than to
embark on a joint project to
decipher themolecular mech-
anisms of synaptic trans-
mitter release. ‘‘Yeah, sure!’’
I thought, very skeptically,
‘‘Good luck!’’ I was of course
aware of the importance
of neurotransmitter release.
I knew that transmitters are
released from synaptic vesi-
cles with extreme speed and
precision and that the releaseis triggered by Ca2+ ions in a highly coop-
erative manner—but not a single mole-
cular component of the synaptic release
machinery had been discovered at the
time.
I was a ‘‘doubting Thomas,’’ soon to be
refuted, because Su¨dhof subsequently
ploughed through the field of molecular
neuroscience like a bulldozer. Using,
for example, protein purification and pro-
tein-interaction screens, and inspired
by genetic studies in Saccharomyces
cerevisiae, Caenorhabditis elegans, and
Drosophila melanogaster, he discovered
many dozens of synaptic vesicle proteins
and other synapse components—and
importantly, he invested early on inmouse
genetic and electrophysiological ap-
proaches to study the function of the
newly characterized proteins in neurons.
Among many important discoveries,
Su¨dhof’s lab showed that the SEC1
homolog Munc18 is a key regulator of
the SNARE machinery (Hata et al., 1993),
which controls SNARE complex forma-
tion and is absolutely required for syn-
aptic vesicle fusion (Verhage et al., 2000)
(Figure 1), and that the interplay between
a-Synuclein and CSP controls SNARE
protein stability and SNARE complex
assembly (Chandra et al., 2005). Su¨dhof
highlighted these discoveries in his
Nobel Lecture to indicate that the
SNAREs alone cannot explain the intri-
cacies of synaptic vesicle fusion, such
as the presence of a primed and fusion-
ready pool of vesicles at synapses, and
that the dysfunction of SNAREs and726 Neuron 81, February 19, 2014 ª2014 Elsother presynaptic components may play
key roles in Parkinson’s disease and other
neurological and psychiatric disorders.
However, according to the Scientific
Background provided by the Nobel
Assembly, yet another discovery of the
Su¨dhof laboratory was at least of equal
importance for awarding the 2013 Nobel
Prize, namely the elucidation of the mo-
lecular mechanism by which Ca2+ ions
trigger synaptic vesicle fusion. In 1990,
Su¨dhof determined the primary structure
of Synaptotagmin-1 (Perin et al., 1990), a
synaptic vesicle protein that had previ-
ously been identified by others, and
showed that it contains a tandem of two
C2 domains, which had first been found
in Ca2+-regulated PKC variants. These
structural features of Synaptotagmin-1
indicated a possible role in the Ca2+
sensing step of synaptic vesicle fusion.
Indeed, Su¨dhof then demonstrated Ca2+
binding and Ca2+-dependent phospho-
lipid binding by Synaptotagmin-1 (Brose
et al., 1992), found that Synaptotagmin-1
is required for fast synchronous neuro-
transmitter release (Geppert et al., 1994),
and showed in a very elegant mouse
genetic study by modifying the Ca2+
affinity of Synaptotagmin-1 in vivo that
Synaptotagmin-1 really is the Ca2+ sensor
of synaptic vesicle fusion (Ferna´ndez-
Chaco´n et al., 2001). Subsequently,
Su¨dhof’s group characterized many of
the 16 mammalian Synaptotagmins and
showed that only a subset of family
members are involved in triggering Ca2+-
dependent synaptic vesicle fusion, withevier Inc.different characteristics. The
exact molecular mechanism
by which Synaptotagmins
trigger vesicle fusion in a
Ca2+-stimulated manner has
been a focus of fierce contro-
versy for two decades. The
current consensus is that
both Ca2+-dependent phos-
pholipid binding and Ca2+-
dependent SNARE complex
binding are involved.
Beyond Su¨dhof’s corework
on the role of Synaptotagmins
in Ca2+-dependent synaptic
vesicle fusion, the scientific
justification of the 2013 Nobel
Prize by the Nobel Assembly
highlighted a final achieve-
ment of the Su¨dhof lab, thediscovery and functional characterization
of Complexins (McMahon et al., 1995;
Reim et al., 2001). This is particularly
interesting because Su¨dhof’s view of
Complexin function differs from that of
his colaureate Rothman. While Rothman
emphasized the ‘‘clamp’’ function of
Complexin during his Nobel Lecture,
Su¨dhof interpreted his own work and
that of several other neuroscientists to
indicate that Complexin acts as an
essential positive cofactor of Synapto-
tagmin that activates or ‘‘super-primes’’
SNARE complexes prior to fusion. It
seems that some more model maturation
is required in this regard, that this ‘‘wine’’
has still to age...
Like his colaureates, Su¨dhof ended his
Nobel Lecture with a discourse on a topic
that had not been mentioned in the Scien-
tific Background of the Nobel Prize pro-
vided by the Nobel Assembly, namely the
problem of localized Ca2+ entry in presyn-
aptic terminals. In most synapses studied
so far, the synaptic vesicle fusion machin-
ery is tightly coupled to voltage-gated
calcium channels, which are the source
of the Ca2+ trigger. However, the mecha-
nisms by which such coupling might be
brought about have long been unknown.
Recent work by Su¨dhof and colleagues
has at least partly lifted this secret by
demonstrating that the presynaptic scaf-
foldproteinRIMphysically links the vesicle
priming and releasemachinery to voltage-
gated calcium channels (Kaeser et al.,
2011). As with Schekman’s and Roth-
man’s Nobel Lectures, no such excursus
Neuron
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number of Su¨dhof’s seminal contributions
to our understanding of presynaptic func-
tion is unparalleled by any other scientist
in the field, with his work on the Ca2+ regu-
lation of transmitter release as the abso-
lute highlight. There has been hardly any
scientific meeting in the field of neuronal
cell biology over the last decade where
not a substantial fraction of talks and
posters dealt with proteins that Su¨dhof
had first characterized—which is probably
the best proof of the inspirational and
visionary influence that Su¨dhof’s work
has had in the neurosciences.
A Prize for Three?
In their Nobel Lectures, all three laureates
emphasized the key contributions of their
coworkers and collaborators, and in the
literature citations here, I too have tried to
honor their contributions. But students
and postdocs come and go, whereas
Schekman, Rothman, and Su¨dhof had
the genius and vision to pull off this
amazing example of scientific discovery.
It is therefore no question whatsoever
that the 2013 Nobel Prize in Physiology
or Medicine is extremely well deserved.
As a neuroscientist and member of the
‘‘second generation’’ that followed the
three pioneers, I am just a bit sad that
there was no place for a few more laure-
ates, so that Reinhard Jahn, Su¨dhof’s
long-term ally, and Richard H. Scheller,
a friendly competitor of Su¨dhof and Jahn
for two decades, could have also been
honored. In this regard, cell biologists
may feel similarly about Peter Novick and
Tom Rapoport.
It is a difficult issue, and I do not envy the
members of theNobel Assembly that have
to boil down a prize-worthy discovery to
its essence. Unfortunately, only threecan win, and because of this, the 2013
decision of the Nobel Assembly was
smack on target. Much, much better, by
the way, than the decision for the FIFA
Ballon d’Or 2013, honoring the best
footballer of the world. Regrettably, FIFA
decided by vote of ‘‘experts’’ rather
than after deliberations in a committee
and elected Christiano Ronaldo, le beau,
instead of the somewhat less beautiful
but much more accomplished Franck
Ribe´ry.
Chapeau bas Messieurs Schekman,
Rothman, et Su¨dhof—et Ribe´ry! Aah ...
et Ronaldo!ACKNOWLEDGMENTS
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